Author Correction: Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease

Correction to: Nature Medicine https://doi.org/10.1038/s41591-019-0627-8, published online 7 November 2019.

In the version of this article initially published, there were errors in the categorization of uACR into groups of < 3, 3–30 and > 30 mg mmol^–1: an incorrect proportion of participants were categorized into the > 30 mg mmol^–1 group, but analyses that used uACR as a continuous variable are unaffected. There was an additional error in the calculation of eGFRcr-cys for a small subgroup of women. Consequently, in the ‘Demographics of participants’ section in the Results, the r values between eGFRcys and eGFRcr-cys and between eGFRcr and eGFRcr-cys have been updated; in the ‘Prediction of all-cause mortality and CVD with albuminuria’ section in the Results, “the risk of ESKD increases with higher uACR category” has been changed to “the risk of all outcomes generally increases with higher uACR category”; in the Results, the values in Tables 1–4 have been updated; Figs. 2 and 3 and Supplementary Tables 1–9 have been revised to include updated values, and the Fig. 2 legend has also been updated accordingly; in the Discussion, “In the UK Biobank, only 3.2% of 440,526 participants had uACR > 30 mg mmol⁻¹” has been changed to “In the UK Biobank, only 0.4% of 440,526 participants had uACR > 30 mg mmol⁻¹”; and in the Methods, “categorical NRI was tested for reclassification of patients from ‘low’ to ‘intermediate’ risk” has been changed to “categorical NRI was tested for reclassification of patients from ‘low’ to ‘high’ risk.” The main messages of the paper are unaffected. The errors have been corrected in the HTML and PDF versions of the article.